UBS Group’s Stride LRN Stock Holding History

UBS Group’s Portfolio LRN Stock Details LRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,500	Closed	-$3.05M	–	10909
2025 Q3	$3.05M	Buy	+20,500	New	+$3.01M	﹤0.01%	4536

Other funds holding LRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's LRN Position: Q1 2026 in Review

UBS Group increased its Stride (LRN) stake by 1% in Q1 2026, buying an estimated $500K and bringing the position to 596,187 shares worth $52.6M. The position accounts for 0.01% of the portfolio, ranked #1586.

UBS Group first reported a position in LRN in Q4 2014 and has held it in 44 quarters since. The position peaked at $144M in Q2 2025. 419 funds tracked by Wall St. Rank hold LRN as of Q1 2026.

UBS Group held 596,187 shares of Stride worth $52.6M as of Q1 2026.
UBS Group bought 6,169 Stride shares in Q1 2026, an estimated $500K.
Stride made up 0.01% of UBS Group's portfolio in Q1 2026, its #1586 holding.
UBS Group first reported a position in Stride in Q4 2014 and has held it in 44 quarters since.
UBS Group's Stride position peaked at $144M in Q2 2025.
419 funds tracked by Wall St. Rank held Stride as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.